(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one has been researched along with Psoriasis* in 2 studies
1 trial(s) available for (9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Psoriasis
Article | Year |
---|---|
[Systemic effects of topical application of beclomethasone dipropionate--comparative studies with betamethasone 17-valerate ointment and fluocinonide cream (author's transl)].
Topics: Administration, Topical; Adolescent; Adult; Aged; Beclomethasone; Betamethasone Valerate; Clinical Trials as Topic; Dermatitis, Atopic; Female; Fluocinonide; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis | 1979 |
1 other study(ies) available for (9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Psoriasis
Article | Year |
---|---|
Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
Topics: Administration, Topical; Adolescent; Adult; Aged; Beclomethasone; Betamethasone; Betamethasone Valerate; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Ointments; Psoriasis | 1979 |